News

May 3, 2019

New Imaging-Guided System Helps Surgeons Remove Tiny Ovarian Tumors

News

A new imaging-guided surgical technique that makes ovarian cancer tumors glow under near-infrared light can help surgeons remove tumors as small as 0.3 millimeters, a study in mice shows. The ... Read more

April 29, 2019

Ovarian Cancer Patients Being Recruited to Test HPN536 Immunotherapy in Phase 1/2a Trial

News

Harpoon Therapeutics has begun dosing participants in its Phase 1/2a trial evaluating the investigational immunotherapy HPN536 in patients with advanced cancers that produce the mesothelin protein. The study (NCT03872206) will ... Read more

April 26, 2019

Study Ranks Gene Targets for More Effective, Tailored Cancer Therapies

News

A large-scale screening provided a system to prioritize gene targets for the potential development of tailored cancer therapies. According to the scientists, the findings may also help produce the Cancer ... Read more

April 24, 2019

Surgeons Will Test LUM Imaging System to Better Detect Ovarian, Other Cancer Cells

News

Lumicell is assessing its LUM Imaging System as a means to help surgeons better detect cancer cells that spread into the peritoneum — the membrane lining the abdominal cavity and ... Read more

April 22, 2019

Lynparza Plus Investigational Alpelisib Is Promising for Epithelial Ovarian Cancer

News

A combination of Lynparza (olaparib) and the investigational PI3K inhibitor alpelisib is safe for the treatment of recurrent epithelial ovarian cancer and induces at least stable disease in more than ... Read more

April 17, 2019

BRCA1/2 Protection Factor Decreases over Time in Epithelial Ovarian Cancer, Study Reports

News

Women with invasive epithelial ovarian cancer have better survival rates at five years of diagnosis if they carry mutations in the BRCA1 and BRCA2 genes. However, this benefit decreases over ... Read more

April 15, 2019

Myriad Seeks FDA Approval of myChoice HRD CDx Diagnostic Test for Ovarian Cancer Patients

News

Myriad Genetics has submitted the first part of a premarket approval application with the U.S. Food and Drug Administration for myChoice HRD CDx, a diagnostic test designed to identify ovarian cancer ... Read more

April 12, 2019April 12, 2019

Long-term Use of Oral Contraceptives Protects Against Deadliest Forms of Ovarian Cancer, Large Study Finds

News

Long-term use of oral contraceptives protects women from the most lethal types of ovarian cancers, a large multi-center study has found. The study, “Oral contraceptive use and risk of highly ... Read more

April 10, 2019

Viome and Helomics Team Up to Study Possible Links Between Gut Microbiome and Ovarian Cancer

News

With the aim of advancing personalized therapy, a pilot study will investigate a possible correlation between gut microbiome and ovarian cancer. The investigation is the initial development of a new ... Read more

April 8, 2019

OncLive Summit Looks at Ovarian Cancer and Soft Tissue Sarcoma

News

A recent OncLive State of the Science Summit focused on new therapies and other issues in ovarian cancer and soft tissue sarcoma. The March 26 event in New York was ... Read more